CIK: 1488495 - Address: C/o Third Rock Ventures, Llc,, 29 Newbury Street, 3Rd Floor, Boston, MA 02116
13 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret314-3662172020
S%wins10050500040

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

6/7/21 18:10
6/3/21
RVMDRevolution Medicines, Inc.DEHealthBioPrdBiological Products, (No DiagThird Rock Ventures Ii, L.P.MATS.m-16,40730.210-543-85,912D
5/27/21 17:43
5/25/21
RVMDRevolution Medicines, Inc.DEHealthBioPrdBiological Products, (No DiagThird Rock Ventures Ii, L.P.MATS.m-41,76430.570-1,366-176,455D
5/27/21 17:42
5/25/21
JNCEJounce Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagThird Rock Ventures Ii, L.P.MATS-4,4208.000-553-69,387D
3/3/21 18:00
3/1/21
JNCEJounce Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagThird Rock Ventures Ii, L.P.MATS-17,03811.750-1,450-1210,960D
11/23/20 16:42
11/19/20
JNCEJounce Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagThird Rock Ventures Ii, L.P.MATS-1057.010-1509,361D
11/19/20 17:42
11/17/20
JNCEJounce Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagThird Rock Ventures Ii, L.P.MATS-1097.250-1509,376D
11/6/17 16:00
11/6/17
ALNAAllena Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagThird Rock Ventures Ii, L.P.MATP.d3,01014.00021582,791D
9/27/17 16:01
9/25/17
MYOKMyokardia IncDEHealthDrugPharmaceutical PreparationsThird Rock Ventures Ii, L.P.MATS.m-25,86043.000-601-87,020D
9/12/17 16:05
9/8/17
MYOKMyokardia IncDEHealthDrugPharmaceutical PreparationsThird Rock Ventures Ii, L.P.MATS.m-9,13841.300-221-62135D
3/6/17 19:47
3/2/17
GBTGlobal Blood Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsThird Rock Ventures Ii, L.P.MATS-52,24525.5433-2,045-83420D7464466730140-13029
2/9/17 17:21
2/7/17
BPMCBlueprint Medicines CorpDEHealthDrugPharmaceutical PreparationsThird Rock Ventures Ii, L.P.MATS-35,27535.2812-1,000-184,667D1645120281080-111114
11/16/16 16:12
11/14/16
GBTGlobal Blood Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsThird Rock Ventures Ii, L.P.MATS-38,72019.3615-2,000-551,613D-5510-11174-4-6-934
5/18/16 16:27
5/16/16
SAGESage Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsThird Rock Ventures Ii, L.P.MATS-26,56331.2514-850-174,023D-46-27-6-15-13-61-4-3-81472

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact